{"id":73551,"date":"2026-10-24T11:08:16","date_gmt":"2026-10-24T15:08:16","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/amgen-reports-landmark-survival-data-brazil-court-orders-meta-to-halt-election-interference\/73551\/"},"modified":"2026-10-24T11:08:16","modified_gmt":"2026-10-24T15:08:16","slug":"amgen-reports-landmark-survival-data-brazil-court-orders-meta-to-halt-election-interference","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/amgen-reports-landmark-survival-data-brazil-court-orders-meta-to-halt-election-interference\/73551\/","title":{"rendered":"Amgen Reports Landmark Survival Data; Brazil Court Orders Meta to Halt Election Interference"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Amgen (<a href=\"\/stock\/AMGN\">AMGN<\/a>)<\/strong> announced that its drug <strong>Imdelltra<\/strong>, in combination with <strong>AstraZeneca\u2019s (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> <strong>Imfinzi<\/strong>, reduced the risk of death by <strong>58%<\/strong> in first-line extensive-stage small cell lung cancer (ES-SCLC).<\/li>\n<li>The combination therapy extended <strong>median overall survival to 21.1 months<\/strong>, compared to 12.7 months for patients receiving Imfinzi alone.<\/li>\n<li><strong>Brazil\u2019s Superior Electoral Court (TSE)<\/strong> ordered <strong>Meta (<a href=\"\/stock\/META\">META<\/a>)<\/strong> to stop interfering with political content distribution following allegations of bias from President <strong>Lula\u2019s<\/strong> campaign.<\/li>\n<li>The court has threatened Meta with daily fines of up to <strong>1 million reais ($200,000)<\/strong> if it fails to ensure equal treatment between candidates ahead of Sunday&#39;s presidential runoff.<\/li>\n<\/ul>\n<h2>Amgen\u2019s &quot;Watershed&quot; Breakthrough in Lung Cancer Treatment<\/h2>\n<p><strong>Amgen (<a href=\"\/stock\/AMGN\">AMGN<\/a>)<\/strong> released landmark results from its Phase 3 <strong>DeLLphi-305<\/strong> trial today, showing that <strong>Imdelltra<\/strong> (tarlatamab-dlle) significantly improves survival rates for patients with aggressive lung cancer. When used as a first-line maintenance treatment alongside <strong>AstraZeneca\u2019s (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> <strong>Imfinzi<\/strong> (durvalumab), the regimen more than tripled progression-free survival.<\/p>\n<p>The data, presented at the <strong>ESMO Congress 2026<\/strong>, revealed that nearly <strong>80%<\/strong> of patients on the combination therapy were alive at one year, compared to <strong>53%<\/strong> in the control group. While the safety profile remained consistent with individual medicines, <strong>Grade 3 or higher adverse events<\/strong> occurred in <strong>20.9%<\/strong> of combination patients versus <strong>10.8%<\/strong> for those on Imfinzi alone. Analysts suggest these results could establish a new standard of care for <strong>ES-SCLC<\/strong>, a disease historically known for poor prognosis.<\/p>\n<h2>Brazil\u2019s Electoral Court Cracks Down on Meta and X<\/h2>\n<p>In a major escalation of election oversight, <strong>Brazil\u2019s Superior Electoral Court<\/strong> has ordered <strong>Meta (<a href=\"\/stock\/META\">META<\/a>)<\/strong> to cease any actions that restrict the reach of political content. The ruling follows a formal complaint from President <strong>Luiz In\u00e1cio Lula da Silva\u2019s<\/strong> campaign, which alleged that the company\u2019s algorithms and <strong>Meta AI<\/strong> were suppressing his posts while favoring his opponent, <strong>Fl\u00e1vio Bolsonaro<\/strong>.<\/p>\n<p>The dispute has intensified just days before the high-stakes presidential runoff scheduled for Sunday. Judges have demanded technical explanations from both <strong>Meta (<a href=\"\/stock\/META\">META<\/a>)<\/strong> and <strong>X<\/strong> (formerly Twitter) regarding their content distribution practices. While <strong>Meta<\/strong> has denied any political bias, attributing the issues to &quot;technical problems&quot; and global glitches, the court has doubled non-compliance fines to <strong>1 million reais ($200,000)<\/strong> per day to ensure a level playing field.<\/p>\n<h2>Market Implications and Regulatory Pressure<\/h2>\n<p>The legal pressure in Brazil reflects a growing global trend of judicial intervention in social media&#39;s role during democratic processes. Similar to recent cases in <strong>Germany<\/strong> and <strong>Romania<\/strong>, Brazilian authorities are focusing on algorithmic transparency and the potential for AI-generated content to sway voter sentiment.<\/p>\n<p>For <strong>Amgen (<a href=\"\/stock\/AMGN\">AMGN<\/a>)<\/strong>, the clinical success of <strong>Imdelltra<\/strong> is expected to bolster its oncology portfolio significantly. With a reported <strong>58% reduction in the risk of death<\/strong>, the drug is positioned to capture a substantial share of the maintenance therapy market for small cell lung cancer. <em>Investors are closely watching for further regulatory filings as the company seeks to expand the drug&#39;s label for earlier-line treatment.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Amgen (AMGN) announced that its drug Imdelltra, in combination with AstraZeneca\u2019s (AZN) Imfinzi, reduced the risk of death [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5043,5227,5757,7667,7765,18846,21413],"class_list":["post-73551","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-technology","tag-healthcare","tag-meta-meta-stock-meta","tag-tse","tag-astrazeneca-azn-stock-azn","tag-amgen-amgn-stock-amgn","tag-brazil-elections"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=73551"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73551\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=73551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=73551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=73551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}